You are viewing: US Pharmaceutical Quality Management Software (QMS) Market analysis

The US Pharmaceutical Quality Management Software (QMS) Market was valued at $620.7 Million in 2025 and projected to reach to $1134.2 Million by 2030, representing a compound annual growth rate of 12.8%. The US Pharmaceutical Quality Management Software market is poised for sustained growth through 2030, driven by evolving FDA regulations, increased post-pandemic compliance scrutiny, and the industry's commitment to digital modernization.

US Pharmaceutical Quality Management Software (QMS) Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Pharmaceutical Quality Management Software (QMS) Market Trends and Insights

  • The US market is driven by stringent FDA regulations, increasing compliance requirements, and the pharmaceutical industry's shift toward digital transformation and automation.
  • In the US, manufacturers are investing heavily in QMS solutions to streamline quality operations, reduce regulatory risks, and enhance operational efficiency across manufacturing and distribution networks. The US pharmaceutical sector's emphasis on data integrity, traceability, and real-time monitoring is accelerating QMS adoption across large enterprises and mid-sized manufacturers.
  • The US market benefits from advanced IT infrastructure, high software spending capacity, and a mature regulatory environment that mandates sophisticated quality control systems.
  • By 2030, the US is expected to maintain its position as a leading market for QMS solutions, with continued investment in cloud-based platforms, AI-driven analytics, and integrated quality ecosystems..

Key Market Statistics

  • CAGR (2025-2030) 12.8% CAGR
  • Market Size, 2025 ~USD 620.7 Million
  • Forecast, 2030 ~USD 1134.2 Million
  • Country US

US Pharmaceutical Quality Management Software (QMS) Market Overview

FDA Compliance Driving Adoption :

Stringent FDA regulations and Part 11 compliance requirements are compelling US pharmaceutical manufacturers to adopt advanced QMS solutions to maintain regulatory standards and avoid costly penalties.

Digital Transformation Momentum :

US pharmaceutical companies are accelerating digital transformation initiatives, with QMS software becoming central to modernizing quality operations and reducing manual processes across manufacturing facilities.

Market Valuation Growth :

The US market is valued at $620.7 million in 2025 and is projected to reach $1,134.2 million by 2030, representing a robust 12.8% CAGR driven by increased investment in quality infrastructure.

Automation and Efficiency Gains :

US manufacturers are leveraging QMS software to automate quality control workflows, reduce human error, and improve operational efficiency while maintaining full audit trails for regulatory inspections.

US Pharmaceutical Quality Management Software (QMS) Market Dynamics

  • Pharmaceutical manufacturers across the US are recognizing QMS software as essential infrastructure for managing complex quality processes, ensuring product safety, and maintaining competitive advantage in a highly regulated environment. Investment in cloud-based and AI-enabled QMS solutions is accelerating as US companies seek scalability and real-time visibility into quality metrics.
  • The market will continue to benefit from consolidation among pharmaceutical firms, expansion of biologics manufacturing, and heightened focus on supply chain quality assurance.
  • Strategic partnerships between software vendors and US manufacturers will further drive innovation and market penetration..

Related Ecosystem

Healthcare Analytics

Top Technologies
  • Machine Learning
  • Natural Language Processing (NLP)
  • Blood Pressure Monitors
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Top Companies
  • Oracle Corporation
  • PHILIPS HEALTHCARE
  • Siemens healthineers
  • Zensar Technologies Limited
  • International Business Machines Corporation

    Healthcare It

    Top Technologies
    • Computed Tomography (CT)
    • Machine Learning
    • Magnetic Resonance Imaging (MRI)
    • Natural Language Processing (NLP)
    • Predictive Analytics
    Top Companies
    • CERNER CORPORATION
    • PHILIPS HEALTHCARE
    • Oracle Corporation
    • GE HealthCare Technologies Inc.
    • Siemens healthineers

      Key Takeaways

      • The US Pharmaceutical QMS market is valued at $620.7 million in 2025 and will reach $1,134.2 million by 2030, representing a 12.8% CAGR.
      • FDA compliance and regulatory pressures are primary drivers of QMS adoption across the US pharmaceutical manufacturing sector.
      • The US market is shifting toward cloud-based and AI-enabled QMS solutions to enhance real-time monitoring and data integrity.
      • Large pharmaceutical manufacturers in the US are leading QMS investment, with mid-sized companies increasingly adopting integrated quality platforms.

      Pharmaceutical Quality Management Software (QMS) Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment BIOTECHNOLOGY COMPANIES (End User)
      Forecast Period 2025–2030
      Growth Rate CAGR of 13.3% from 2025 to 2030
      Largest Segment LARGE ENTERPRISES (Enterprise Size)
      Market Size Base Year (Billions) ~USD 1.6 (2025)
      Revenue Forecast (Billions) ~USD 2.98 (2030)
      Segments Covered Process, Application, Enterprise Size, End User, End User 2023–2030

      US Pharmaceutical Quality Management Software (QMS) Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Process

      • Clinical Trials
      • Commercialization, Marketing, & Sales
      • Commercialization, Marketing, And Sales
      • Distribution & Supply Chain
      • Manufacturing/ Production
      • Other Processes
      • Post-Market Surveillance
      • Quality Assurance/ Quality Control
      • Quality Assurance/Quality Control
      • Regulatory Compliance

      By Application

      • Audit & Inspection Management
      • Capa (Corrective & Preventive Action) Management
      • Change Control Management
      • Document Control & Esop
      • Other Applications
      • Regulatory & Compliance Management
      • Risk Management
      • Supplier Quality Management
      • Training Management

      By Enterprise Size

      • Large Enterprises
      • Small & Medium Enterprises

      By End User

      • Biotechnology Companies
      • Contract Development & Manufacturing Organizations (Cdmo)
      • Contract Development And Manufacturing Organization (Cdmo)
      • Contract Development And Manufacturing Organization (Cdmos)
      • Contract Development And Manufacturing Organizations (Cdmo)
      • Contract Research Organization (Cro)
      • Contract Research Organizations (Cro)
      • Contract Research Organizations (Cros)
      • Other End Users
      • Pharmaceutical Companies

      By End User 2023–2030

      • Biotechnology Companies
      • Contract Development And Manufacturing Organizations (Cdmo)
      • Contract Research Organizations (Cro)
      • Other End Users
      • Pharmaceutical Companies

      US: PHARMACEUTICAL QUALITY MANAGEMENT SOFTWARE MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      BIOTECHNOLOGY COMPANIES111.9126.1142.4161182.4207235.4268.113.5
      CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMO)72.580.890.2100.8113126.9142.7160.712.3
      CONTRACT RESEARCH ORGANIZATIONS (CRO)80.790.2100.9113126.9142.8160.9181.612.5
      OTHER END USERS15.316.61819.42122.724.526.58.1
      PHARMACEUTICAL COMPANIES213.4239.5269.3303.4342.4387.2438.4497.413.1
      TOTAL493.9553.2620.7697.7785.8886.61001.91134.212.8

      Target Audience

      • QMS Software Vendors : Vendors need US market data to refine product roadmaps, identify customer acquisition opportunities, benchmark against competitors, and develop FDA-compliant solutions tailored to American manufacturers.
      • Pharmaceutical Manufacturers : US pharma companies require market intelligence to evaluate QMS solutions, understand peer adoption rates, assess ROI benchmarks, and make informed technology investment decisions aligned with regulatory requirements.
      • Private Equity & Investors : Investment firms need comprehensive US market analysis to identify acquisition targets, assess growth potential of QMS vendors, and evaluate market consolidation opportunities in the pharmaceutical software space.
      • Management Consultants : Consultants advising US pharmaceutical clients need detailed market data to support digital transformation recommendations, validate technology strategies, and benchmark operational improvements against industry standards.
      • Healthcare IT Analysts : Industry analysts and research professionals require US-specific market metrics, trend analysis, and forecasts to publish reports, advise stakeholders, and track the evolution of pharmaceutical quality management technology.

      Key Companies in the US Pharmaceutical Quality Management Software (QMS) Market

      CompanyHQOwnershipStrongest segments
      HONEYWELL INTERNATIONAL INC.United StatesPublic CompanyIndustrial Automation (control, instrumentation, smart energy, sensing, PPE, software and analytics),Building Automation (building control software, energy management, security, fire, services),Energy and Sustainability Solutions / UOP (licensed process technologies, equipment, catalysts, software),
      IQVIAUnited StatesPublic CompanyTechnology & Analytics Solutions,Research & Development Solutions,Contract Sales & Medical Solutions,
      VEEVA SYSTEMS INC.United StatesPublic CompanyVeeva Commercial Cloud (Vault CRM, Medical, PromoMats, Crossix, CRM Pulse),Veeva Development Cloud (Clinical Platform, Clinical Data Management, Safety, RIM),Veeva Quality Cloud,
      DASSAULT SYSTèMESFrancePublic Company3D Modeling (CATIA, SOLIDWORKS, GEOVIA, BIOVIA),PLM & Collaboration (ENOVIA, CENTRIC PLM, 3DEXCITE, 3DEXPERIENCE platform),Simulation & Manufacturing (SIMULIA, DELMIA, 3DVIA),
      HEXAGON ABSwedenPublic CompanyManufacturing Intelligence (metrology, CAD/CAM, CAE, quality software),Geosystems (surveying, mapping, laser scanning, AEC solutions),Autonomous Solutions and Positioning (GNSS, anti-jam, machine control, autonomy),
      IDEAGENUnited KingdomPrivate CompanyRegulatory Compliance & GRC Platforms,Operational Performance & Quality Management,Workplace Health & Safety (incl. Reactec),
      SOFTEXPERTBrazilPrivate CompanyBusiness Process & Corporate Performance Management,Enterprise Quality, Risk & GRC,Enterprise Content & Asset Management,
      INSTEMUnited KingdomPrivate CompanyResearch study management software (discovery, preclinical, early clinical),Regulatory submission solutions (SEND generation, conversion, validation),In silico and data insights solutions,
      INTELLECT, INCIndiaPublic CompanyWholesale & Corporate Banking (lending, payments, liquidity, trade, treasury),Consumer Banking (core, lending, cards, digital engagement),Wealth, Capital Markets, and Insurance Platforms,

      HONEYWELL INTERNATIONAL INC.

      Honeywell International Inc. is a diversified technology and manufacturing company founded in 1885 and headquartered in the United States. With 101,000 employees, the publicly traded company operates across multiple industrial sectors including aerospace, building technologies, and performance materials.

      IQVIA

      IQVIA is a United States-based public company with 93,000 employees that provides integrated information and technology solutions to the life sciences industry.

      VEEVA SYSTEMS INC.

      Veeva Systems Inc. is a United States public company founded in 2007 with 7,928 employees that provides cloud-based software solutions for the life sciences industry.

      DASSAULT SYSTèMES

      Dassault Systèmes is a French public company founded in 1981 with 25,724 employees that provides 3D design, digital mock-up, and product lifecycle management software solutions.

      HEXAGON AB

      Hexagon AB is a Swedish public company founded in 1975 with 16,118 employees that provides digital solutions and software for industrial and geospatial applications.

      IDEAGEN

      Ideagen is a United Kingdom-based private company founded in 1993 with 697 employees that develops software solutions for quality, risk, and compliance management.

      SOFTEXPERT

      SoftExpert is a Brazil-based private company founded in 1995 with 170 employees that provides software solutions for process management, quality, and compliance.

      INSTEM

      Instem is a United Kingdom-based private company founded in 1969 with 510 employees that provides software and services for the life sciences and pharmaceutical industries.

      INTELLECT, INC

      Intellect, Inc. is an India-based public company founded in 2011 with 6,876 employees that provides software and IT solutions for various industries.

      Reasons to Buy this Report

      • Regulatory Intelligence for US Market : Gain deep insights into FDA-specific compliance requirements, Part 11 standards, and regulatory trends shaping QMS adoption decisions across US pharmaceutical manufacturers.
      • Competitive Landscape Analysis : Understand the competitive positioning of QMS vendors in the US market, identify key players, market share dynamics, and differentiation strategies specific to American pharmaceutical operations.
      • Investment and Growth Opportunities : Identify high-growth segments within the US market, emerging technology trends, and investment hotspots for venture capital, private equity, and strategic corporate acquisitions.
      • Customer Segmentation Insights : Access detailed analysis of US pharmaceutical manufacturers by size, therapeutic area, and manufacturing complexity to tailor product offerings and go-to-market strategies effectively.
      • Technology Adoption Trends : Discover which QMS technologies (cloud, AI, IoT, blockchain) are gaining traction among US pharma companies and forecast future adoption patterns through 2030.

      Frequently asked questions

      What is the current size of the US Pharmaceutical QMS market?

      The US Pharmaceutical QMS market is valued at $620.7 million in 2025 and is projected to grow to $1,134.2 million by 2030.

      What is the growth rate of the US Pharmaceutical QMS market?

      The US Pharmaceutical QMS market is expected to grow at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2030.

      What are the main drivers of QMS adoption in the US?

      Key drivers include FDA regulatory compliance requirements, digital transformation initiatives, the need for data integrity and traceability, and operational efficiency improvements in US pharmaceutical manufacturing.

      Which segments are leading QMS adoption in the US market?

      Large pharmaceutical manufacturers and contract manufacturing organizations (CMOs) in the US are leading QMS adoption, with increasing uptake among mid-sized companies seeking integrated quality solutions.

      What technology trends are shaping the US QMS market?

      Cloud-based deployment, artificial intelligence-driven analytics, real-time monitoring capabilities, and integration with enterprise resource planning (ERP) systems are key technology trends in the US QMS market.

      RESEARCH METHODOLOGY

      The study involved several key activities to estimate the current size of the pharmaceutical quality management software (QMS) market. Extensive secondary research was conducted to gather information on this market. The next step was to validate the findings, assumptions, and size estimates by consulting industry experts throughout the value chain through primary research. We employed various methods, including top-down and bottom-up approaches, to estimate the overall market size. Following this, we utilized market segmentation and data triangulation techniques to determine the size of specific segments and subsegments within the pharmaceutical quality management softwarecare market.

      Secondary Research

      This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing pharmaceutical quality management software care solutions is assessed using secondary data from both paid and free sources. This involves analysing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

      Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the pharmaceutical quality management software market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

      Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

      After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyse industry trends, evaluate the competitive landscape of pharmaceutical quality management software care offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

      In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

      Pharmaceutical Quality Management Software Market
 Size, and Share

      Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by process, application, enterprise size, end users, and region).

      Pharmaceutical Quality Management Software Market: Top-Down and Bottom-Up Approach

      Pharmaceutical Quality Management Software Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the pharmaceutical quality management software market.

      Market Definition

      Pharmaceutical quality management software is a formalized, electronic system designed to document, automate, and manage all processes, procedures, and responsibilities associated with ensuring the quality and regulatory compliance of pharmaceutical products throughout their lifecycle. It serves as a centralized platform for managing critical quality activities including document control, SOPs, CAPA, audits, training, risk management, and supplier quality to ensure product safety, efficacy, and regulatory compliance..

      Key Stakeholders

      • Pharmaceutical companies
      • Pharmaceutical quality management software Providers
      • Biotechnology firms
      • Academic Research Institutes
      • Contract Manufacturing Organizations
      • Contract Research Organizations
      • Market Research and Consulting Firms
      • Regulatory Authorities / Agencies
      • Quality Assurance & Quality Control Departments
      • Research & Development (R&D) Teams
      • Third-party Auditors / Inspections Bodies
      • Suppliers / Raw Material Vendors

      Report Objectives

      • To define, describe, and forecast the global pharmaceutical quality management software market based on process, application, enterprise size, end users, and region.
      • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pharmaceutical quality management software market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the pharmaceutical quality management software market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
      • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the pharmaceutical quality management software market
      • To benchmark players within the pharmaceutical quality management software market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe Pharmaceutical quality management software Market into Denmark, Norway, and others
      • Further breakdown of the Rest of Asia Pacific Pharmaceutical quality management software Market into Vietnam, Pakistan, New Zealand, and others
      • Further breakdown of the Rest of Latin America Pharmaceutical quality management software Market into Argentina, Chile, Colombia, and others
      • Further breakdown of the Rest of Middle East & Africa Pharmaceutical quality management software Market into Egypt, Nigeria, Israel, and others

      Get the Full Pharmaceutical Quality Management Software (QMS) Market Report

      Full forecast, segment splits, and company analysis for all Pharmaceutical Quality Management Software (QMS) Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status